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A preliminary result from a cohort study on the association ofafamily history ofcancerwith mortality
is discussed in this paper. Among 2200 patients (1912 males and 288 females) gastrectomized because of
benign gastric diseases, 274 male patients, and 40 female patients had a family history of cancer. During
2750 person-years ofobservation, 22 patients with the family history ofcancer were found to be dead and
111 patients without the family history died during 17,527 person-years, giving a relative risk of 1.26 (not
significant). We focused on the male subjects that were followed up for more than 10 years; however, the
observed/expected ratio ofcancerdeaths for subjects with afamily history ofcancer was about four times
higher than that for those without family history. Since case-control studies on family history are vul-
nerable to biased recall and interchangeability ofcases, more cohort studies like the present study should
be conducted to assess the association of the family history of cancer.
Introduction
Considering recent advances in carcinogenesis in-
cluding oncogenes, epidemiological studies should be
carried out regarding genetic traits and the environ-
ment.
Studying family history is one of the ways to deter-
minethegeneticfactor oncarcinogenesis, althoughfam-
ily members have both the same genetic traits and sim-
ilar environmental exposures during their lives.
There have been many reports showing familial ag-
gregation of cancer, and the term "cancer family syn-
drome" for adenocarcinoma has been used (1). There
are also many reports that showed a higher risk of can-
cer among those with a family history of cancer than
among those without it (2,3). Most of the reports are
based on case-control studies, and a few cohort studies
were conducted on the relationship of cancer risk with
the family history of cancer.
Although conducting case-control studies presents
fewer difficulties in terms of time and cost, those that
were focused on the family history tended to be very
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vulnerable to biased recall (4), comparability including
interchangeability ofcases (5), and other problems.
This paper demonstrates a preliminary result from a
cohort study on patients gastrectomized because ofbe-
nigngastricdiseases. Thepurposesoftheoriginalstudy
(6) were first to measure the general prognosis, that is,
the survival experience after gastrectomy; second, to
examine how gastrectomy is associated with gastric
stump cancer; and third, to determine which factors
contributed to the mortality pattern among the gas-
trectomized patients.
The aim ofthe present study is to examine the roles
of family history for cancer incidence. We also consid-
eredtheadvantagesanddisadvantagesofcohortstudies
forevaluatingthe association offamilyhistoryofcancer
with cancer risk.
Materials and Methods
Patients with benign gastric diseases who had re-
ceived a gastrectomy during the period from August
1972 to December 1979 at one private gastrointestinal
hospitalinNagoya, AichiPrefecture,Japan, werelisted
as eligible subjects. Almost all surgicaloperations were
performed by the three surgeons in the hospital, and
oneexperiencedpathologisthistologicallyscrutinizedall
the resected specimens to confirm the diagnosis ofbe-
nign diseases. All the patients were interviewed bytheSHIBATA ETAL.
three surgeons, with particular attention to family his-
tory, previous illness, smokingand drinkinghabits, and
other factors.
Among 2200 listed patients (1912 males and 288 fe-
males), 274 males and 40 females were found to have
had first- and/or second-degree relatives with cancer
(parents, children, grandparents, siblings, uncles,
aunts, nephews, and nieces). They were followed up
until May 1986 by periodical check-ups and a question-
naire that was mailed out. When the patients could not
be followed up because theyhad moved out ofthe town,
had died, or because ofother reasons, the survival sta-
tus was referred to the offices of population registry
(Honseki). Finally, information was obtained on 98.8%
of the male patients and 96.5% of the female patients.
For the patients reported to be dead, the death certifi-
cates were referred to the registration offices in order
to confirm the causes of death.
As a reference, expected mortality was calculated
separately for the patients with and without a family
history of cancer. Calculation ofthe expected numbers
was based on the observed person-years ofeach patient
group by age multiplied by sex-specific mortality rates
ofthe 5-year age group in Aichi Prefecture, 1970, 1975,
1980, and 1983.
Results
Age and sex distributions of the subjects are shown
in Table 1; 14.3% ofthe male patients and 13.9% ofthe
female patients had a family history of cancer. The per-
centage of the with-history patients among the male
patients who were 30 to 69 years of age ranged from
13 to 17%, and there was little difference among age
groups; 22 to 24% ofthe female subjects from 30 to 49
years of age had a family history of cancer, while about
15% of the female patients in their 20s and 50s had a
family history of cancer. The mean age at the time of
the surgical operation was 45.1 years old for with-his-
tory patients and 43.3 for without-history patients.
Thefrequency oftherelatives' cancerbysiteisshown
inTable2; 64.2% ofmaleprobands and a58.5% offemale
probands had a relative who had a history of stomach
cancer. Forthefemaleprobands, theproportionofcolon
cancer and liver cancer was relatively high while the
proportion ofuterine cancer was low (7.8%).
Table 3 shows the distribution of relatives who had
a history of cancer. The proportion offathers was high-
est (about 31%); the proportion of siblings was about
two times higher among female probands than among
male probands, though the proportion of uncles and
aunts was higher among male probands.
Table 4 shows the smoking rate among the subjects
by family history. Each subgroup showed a higher rate
than the smoking rate among the general population in
Japan. The smoking rate among the male with-history
patients was slightly higher than that among without-
history patients. The difference was statistically sig-
nificant. There was no statisticallysignificant difference
between the female with-history patients and without-
history patients.
The rates of alcohol drinking by family history is
shown in Table 5. The rate for the male with-history
subjects was not statistically different from that for
without-history subjects. The female with-history pa-
tients showed a higher drinking rate than without-his-
tory patients.
Table 6 shows serum total cholesterol and total pro-
tein of the patients, which might be regarded as bio-
logical markers of nutrition and dietary habit that can
be related to cancer. There was no difference between
the with-history subjects and without-history subjects.
However, the serum total protein was slightly higher
among the without-history male patients than among
the with-history patients.
The with-history patients were followed up for 9.0
years and the without-history patients, for 9.4 years on
an average. The person-years ofobservation were2,750
and 17,527, respectively. Twenty-two patients with
family history and 111 patients without family history
were found tobe dead, giving arelativeriskof1.26 (not
significant). Among those, 3 patients and 22 patients
had died of cancer. The relative risk was 0.87 (not sig-
nificant).
Table 7 shows the observed and expected numbers
of deaths from all causes by sex. The ratio of the ob-
served to the expected (O/E ratio) was less than unity
except that forthe male with-history patients. The sta-
tistically significant O/E ratio was not observed. The
ratio ofthe O/E ratio ofthe with-history patients to the
without-history patients was 1.22 in males and 0.53 in
females.
Table 1. Age and sex distribution of subjects by a family history of cancer.
Males Females
Age (+) History (-) History Total (+) History (-) History Total
0-19 3 27 30 0 3 3
20-29 30 252 282 3 17 20
30-39 62 416 478 10 36 46
40-49 84 484 568 9 59 68
50-59 55 276 331 12 69 81
60-69 36 172 208 6 59 65
70-79 3 12 15 0 5 5
Total 273 1639 1912 40 248 288
(%) (14.3) (85.7) (100.0) (13.9) (86.1) (100.0)
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Table 2. Frequency of relatives' cancer by site.
Proband
Site of relatives' cancer Male (%) Female (%)
Stomach 194 (64.2) 30 (58.8)
Lung 5 ( 1.9) 1 ( 2.0)
Uterus 14 ( 4.6) 4 ( 7.8)
Colon 13 ( 4.3) 7 (13.7)
Breast 4 ( 1.3) 0 ( 0.0)
Liver 10 ( 3.3) 5 ( 9.8)
Esophagus 12 ( 4.0) 0 ( 0.0)
Other and unknown 50 (16.6) 4 ( 7.8)
Total 302 (100) 51 (100)
Table 3. Numbers of relatives with cancer.
Proband
Relative Male (%) Female (%)
Fathers 94 (31.1) 16 (31.4)
Mothers 50 (16.6) 9 (17.6)
Grandparents 32 (20.6) 5 ( 9.8)
Siblings 34 (11.3) 12 (23.5)
Uncles and aunts 54 (17.9) 6 (11.8)
Nephews and nieces 4 ( 1.3) 0 ( 0.0)
Children 6 ( 2.0) 0 ( 0.0)
Not specified 28 ( 9.3) 3 ( 5.9)
Total 302 (100) 51 (100)
Table 4. Percentage of smokers among the subjects by family
history of cancer.
Cancer Male, % Female, %
(+) History 93.30 50.0
(-) History 88.20 35.0
p < 0.05 Not significant
Table 5. Percentage of drinkers among the subjects by family
history of cancer.
Cancer Male, % Female, %
(+) History 58.9 26.5
(-) History 56.9 13.4
Not significant p < 0.05
Table 6. Serum total cholesterol and total protein ofthe
subjects by family history of cancer.
Cancer
(+) History
(-) History
aNS, not significant.
Total cholesterol,
mg/dL
Male Female
160.1 171.1
159.5 172.3
NS" NS
Total protein,
g/dL
Male Female
7.11 7.26
7.24 7.31
p < 0.01 NS
Observed cancer deaths were fewer than the ex-
pected in any subgroup (Table 8). The O/E ratio ofthe
with-history patients did not exceedthatofthewithout-
history patients, although the number ofthe observed
was very small. But focusing on the male patients ob-
served for more than 10 years, we recognized that the
Table 7. Observed (0) and expected (E) numbers of deaths from
all causes by family history of cancer.
Males Females
(+) History (-) History (+) History (-) History
O 21.00 95.00 1.00 16.00
E 20.00 109.90 2.30 17.50
O/E ratio 1.05 0.86 0.48 0.91
Table 8. Observed (0) and expected (E) numbers ofdeaths from
cancer by family history of cancer.
Males Females
(+) History (-) History (+) History (-) History
O 3.00 18.00 0.00 4.00
E 6.10 33.3 0.40 5.40
O/E ratio 0.49 0.54* 0.00 0.76
*p < 0.05.
Table 9. Observed (0) and expected (E) numbers of deaths from
all causes and cancer by family history for over 10 years from
gastrectomy in males.
Death Cancer 0 E O/E
All causes (+) History 3 1.8 1.63
(-) History 13 11.5 1.13
Cancer (+) History 2 0.6 3.45
(-) History 3 3.6 0.84
O/E ratio ofcancer deaths forwith-history subjects was
about four times higher than that for without-history
patients, as is shown in Table 9.
Discussion
The relative risk ofhaving a family history ofcancer
seems to be overestimated from case-control studies
because ofmore serious recall in cases than in controls.
There are no good methods to avoid the recall bias,
especially when healthy controls are used. An adoption
of controls with the other serious diseases (7) may be
an alternative way to avoid the bias as long as the risk
ofthe adopted controls is regarded as that in a general
population.
Sometimes those patients whose relatives are se-
lected as the case ofthe case-control study may be also
included in the study. In that case, the independence
of sampling of the subjects is not presumed, i.e., the
problem of interchangeability; it also favors overesti-
mation ofthe relative risk.
The comparison of the risk between those with and
without a family history of cancer in a cohort study is
free from the two previously mentioned influences.
In our study 14.3% of male patients and 13.9% of
female patients had a family history of cancer. These
percentages seem to be lower than the expected, con-
sideringfamilial treestudies (1). Thepercentageoffam-
ily history for stomach cancer patients who were sim-
ilarly examined in the same hospital, however, was
26.3% formales and 28.3% forfemales, whichwas quite
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comparable with other studies, e.g., 24.4% inmale can-
cer patients and 24.6% in female cancer patients listed
in the Aichi Cancer Registry (7). Therefore, family his-
tory records on medical charts at this hospital seemed
to be evaluative.
Thelowpercentagesoffamilyhistoryofcanceramong
the subjects maybe duetothefactthatthe crude death
rate of cancer in Japan was around 60% of that found
in European countries (8). Judgingfromthe occurrence
of cancer in Japan between 1950 and 1970, the rate of
the subjects with a family history of cancer and the
proportionofstomachcancerfoundamongtherelatives'
cancer did not seem to be deviated. On the other hand,
the low proportion of liver cancer may have resulted
from poor diagnostic techniques. The lower proportion
ofuterine cancer may be due either to recall bias, or to
the different socioeconomic status among the subjects
and the general population.
Misclassification between the with-history patients
and without-history patients seem to be unavoidable
becausetheinformationonfamilyhistorywereobtained
only by interviewing subjects and/or their relatives
without any medical confirmation. In this cohort study,
however, the misclassification, if any, was thought to
be nonselective. The misclassification may dilute differ-
enceinriskandreducethestatisticalpower. Evenwhen
the nonselective misclassification does not occur, a
larger number of subjects are required in a cohort
study, which seems to be a demerit in comparison with
case-control studies. Provided that the relative risk is
morethantwo, andmortalityrateofthewithout-history
exceeds 100 per 100,000 person-years, at least 23,500
person-years are necessary for each group with a error
of0.05 and a power of80%.
Concerning the association ofa family history ofcan-
cer with the risk of cancer, we have to consider some
other points.
Mean Age ofSubjects. If the mean age of the pa-
tients at their surgical operation had been older, we
could have observed larger number of deaths and the
result would have been demonstrated more clearly.
Number ofBloodRelatives ofEach Subject. The
more relatives a subject had, the more probability the
subject had of having relatives with cancer. In this
study, the data on the size offamily were notavailable,
but this problem has to be considered if we can obtain
the information on family size.
Cases ThatHave Two orMoreRelatives with Can-
cer. In our study, 11.8% males with-history patients
and 21.7% females with-history patients had two or
more relatives with a family history ofcancer. Because
there were only a small number of subjects who had
two relatives with cancer, wedid notanalyze them sep-
arately. The low percentages do not seem to be attrib-
utable to recall bias, considering the relatively young
agesoftheprobandsandthelowrateofcancermortality
in the past.
The high smoking rate for both male and female sub-
jects may be associated with the fact that the patients
of benign gastroduodenal ulcer show a high smoking
rate; this may be because the socioeconomic status of
the subjects was different from the general population.
Althoughthere were statistically significant differences
in the smoking rate between the with-history patients
andthewithout-historypatients, the5%differencedoes
not seem to largely affect the occurrence of cancers
except lung cancer.
The rate of alcohol drinldng among female with-his-
tory subjects was significantly higherthan that ofwith-
out-history subjects, and this difference needs to be
taken into account in the follow-up study in the future.
There was no difference in serum total cholesterol
between the with-history patients and those without-
history. The serum total protein was lower among the
with-history patients than among those patients with-
out-history.
So the two subgroups (with-history group and with-
out-history group) seemed to be comparable from the
viewpoint of several life-style factors that have rele-
vance to the occurrence ofcancer.
The follow-up for an average of 9 years did not lead
tothesignificantlyhighrelativeriskforthewith-history
patients. This may be because the subjects at surgical
operation were young on the average and the corre-
sponding low mortality rate from cancer and other dis-
eases. The insignificant relative risk may be also be-
cause ofthe small number ofthe with-history subjects.
The reason why the O/E ratios ofcancer death were
low both for the with-history patients and for without-
history patients was not clarified. This may have been
the result ofthe gastrectomy, because stomach cancer
has the highest probability of developing among Japa-
nese people. Another possible explanation is that the
educationbythesurgeons onlifestyleaftergastrectomy
may have had the effect ofreducing their mortality.
Thispreliminary result demonstrated thatthosewith
afamilyhistory ofcancerhad aslightlyelevated, never-
theless not significant risk of mortality from all causes
and cancer risk. The observed person-years were not
enough to evaluate the relative risk of cancer death.
Since the subjects were selected from patients gastrec-
toniized because of benign upper gastrointestinal dis-
eases, we have to be careful to extrapolate this result
inthegeneralpopulation. Inaddition, theobservedper-
son-years were not enough to evaluate the relative risk
ofcancer death. However, the present study could sug-
gest that cohort study is adequate for assessing the
associationoffamilyhistoryofcancerwithriskofcancer
when a large cohort can be followed up.
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